Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients

Lay Summary

Determining how a cancer will behave can allow treatment modifications to improve outcomes. Genetic analysis of the cancer cells can enhance the prediction of risk.

Abstract

Prediction of aggressive clinical behaviour can be enhanced by the detection of copy number change in the plasma cells.

Related Resources

No resources available. If you are one of the authors of this article, you can start contributing here through

article promotion page
{{resource.addedByName}} {{vm.formatShortDate(resource.addedOn)}}
{{resource.viewsCount || 0}}
{{resource.ogData.description}}
    Publication Metrics
    Views 0
    Cited-by Count 0

    Citation Downloads
    BibTeX 0
    EndNote 0
    RIS 0